Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,500 | 6,375 | 4,473 | 5,230 | 6,686 |
| TOTAL | $6,063 | $7,095 | $4,901 | $5,947 | $7,560 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 101 | 101 | 101 | 101 | 101 |
| TOTAL | $101 | $101 | $101 | $101 | $101 |
| Total Assets | $6,164 | $7,196 | $5,002 | $6,048 | $7,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 699 | 265 | 434 | 202 | 744 |
| Accrued Expenses | 442 | 380 | 164 | 145 | 231 |
| TOTAL | $1,141 | $645 | $598 | $347 | $975 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 151,049 | 151,049 | 151,049 |
| TOTAL | $N/A | $N/A | $151,049 | $151,049 | $151,049 |
| Total Liabilities | $1,141 | $645 | $151,647 | $151,396 | $152,024 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,430 | 75,462 | 75,462 | 75,462 | 75,462 |
| Common Shares | 75 | 75 | 75 | 75 | 75 |
| Retained earnings | -308,920 | -307,314 | -460,418 | -459,030 | -457,955 |
| Other shareholders' equity | 4,295 | 2,577 | 2,577 | 2,597 | 2,864 |
| TOTAL | $5,023 | $6,551 | $-146,645 | $-145,348 | $-144,363 |
| Total Liabilities And Equity | $6,164 | $7,196 | $5,002 | $6,048 | $7,661 |